DK1735321T3 - Fremgangsmåde til fremstilling af rapamycin 42-estere og FK-506 32-estere med dicarboxylsyre, precursors for rapamycinkonjugater og antistoffer - Google Patents

Fremgangsmåde til fremstilling af rapamycin 42-estere og FK-506 32-estere med dicarboxylsyre, precursors for rapamycinkonjugater og antistoffer

Info

Publication number
DK1735321T3
DK1735321T3 DK05735488T DK05735488T DK1735321T3 DK 1735321 T3 DK1735321 T3 DK 1735321T3 DK 05735488 T DK05735488 T DK 05735488T DK 05735488 T DK05735488 T DK 05735488T DK 1735321 T3 DK1735321 T3 DK 1735321T3
Authority
DK
Denmark
Prior art keywords
rapamycin
esters
dicarboxylic acid
precursors
antibodies
Prior art date
Application number
DK05735488T
Other languages
Danish (da)
English (en)
Inventor
Jianxin Gu
Ping Cai
Mark E Ruppen
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1735321T3 publication Critical patent/DK1735321T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK05735488T 2004-04-14 2005-04-12 Fremgangsmåde til fremstilling af rapamycin 42-estere og FK-506 32-estere med dicarboxylsyre, precursors for rapamycinkonjugater og antistoffer DK1735321T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56196604P 2004-04-14 2004-04-14
PCT/US2005/012268 WO2005105812A1 (en) 2004-04-14 2005-04-12 Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies

Publications (1)

Publication Number Publication Date
DK1735321T3 true DK1735321T3 (da) 2009-01-12

Family

ID=34965703

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05735488T DK1735321T3 (da) 2004-04-14 2005-04-12 Fremgangsmåde til fremstilling af rapamycin 42-estere og FK-506 32-estere med dicarboxylsyre, precursors for rapamycinkonjugater og antistoffer

Country Status (14)

Country Link
US (2) US7445916B2 (de)
EP (1) EP1735321B1 (de)
JP (1) JP2007532655A (de)
CN (1) CN1942478A (de)
AT (1) ATE410431T1 (de)
AU (1) AU2005238432A1 (de)
BR (1) BRPI0509810A (de)
CA (1) CA2562962A1 (de)
DE (1) DE602005010228D1 (de)
DK (1) DK1735321T3 (de)
ES (1) ES2313328T3 (de)
MX (1) MXPA06011882A (de)
PL (1) PL1735321T3 (de)
WO (1) WO2005105812A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ537829A (en) * 2002-07-30 2006-09-29 Wyeth Corp Parenteral formulations containing a rapamycin hydroxyester
US7445916B2 (en) * 2004-04-14 2008-11-04 Wyeth Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
JP2007534337A (ja) * 2004-04-27 2007-11-29 ワイス ラパマイシン特異的メチラーゼを用いるラパマイシンの標識
PA8641501A1 (es) * 2004-08-10 2006-09-08 Wyeth Corp Derivados de cci-779 y metodo para su preparacion
KR20080077147A (ko) * 2005-12-07 2008-08-21 와이어쓰 결정성 라파마이신의 제조 방법 및 시차 주사 열량계를사용하는 라파마이신 화합물의 결정화도의 측정 방법
US7622578B2 (en) * 2005-12-07 2009-11-24 Wyeth Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
RU2008121240A (ru) * 2005-12-07 2010-01-20 Вайет (Us) Способ получения очищенного кристаллического cci-779
AU2007223963A1 (en) * 2006-03-07 2007-09-13 Wyeth Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants
US8022188B2 (en) * 2006-04-24 2011-09-20 Abbott Laboratories Immunosuppressant binding antibodies and methods of obtaining and using same
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US20080175887A1 (en) 2006-11-20 2008-07-24 Lixiao Wang Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
TW200845960A (en) * 2007-04-05 2008-12-01 Wyeth Corp Wortmannin-rapalog conjugate and uses thereof
WO2010024898A2 (en) 2008-08-29 2010-03-04 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
EP2365802B1 (de) 2008-11-11 2017-08-02 The Board of Regents,The University of Texas System Mikrokapseln von rapamycin und deren verwendung zur behandlung von krebs
US9283211B1 (en) 2009-11-11 2016-03-15 Rapamycin Holdings, Llc Oral rapamycin preparation and use for stomatitis
IN2015DN00694A (de) * 2012-08-16 2015-06-26 Pfizer
EP2968281B1 (de) 2013-03-13 2020-08-05 The Board of Regents of The University of Texas System Mtor-hemmer zur vorbeugung von darmpolypenwachstum
CA3206208A1 (en) 2013-12-31 2015-07-09 Rapamycin Holdings, Llc Oral rapamycin nanoparticle preparations and use
US9700544B2 (en) 2013-12-31 2017-07-11 Neal K Vail Oral rapamycin nanoparticle preparations
EP3624863B1 (de) 2017-05-15 2021-04-14 C.R. Bard, Inc. Medizinische vorrichtung mit wirkstofffreisetzender beschichtung und zwischenschicht
EP3880266A1 (de) 2018-11-14 2021-09-22 Lutonix, Inc. Medizinische vorrichtung mit wirkstofffreisetzender beschichtung auf modifizierter vorrichtungsoberfläche
EP3952937A1 (de) 2019-04-08 2022-02-16 Bard Peripheral Vascular, Inc. Medizinische vorrichtung mit wirkstofffreisetzender beschichtung auf modifizierter vorrichtungsoberfläche

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US4316885A (en) 1980-08-25 1982-02-23 Ayerst, Mckenna And Harrison, Inc. Acyl derivatives of rapamycin
US4650803A (en) 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
US5210030A (en) * 1990-06-25 1993-05-11 Merck & Co., Inc. Process for selectively acylating immunomycin
US5023264A (en) 1990-07-16 1991-06-11 American Home Products Corporation Rapamycin oximes
US5130307A (en) 1990-09-28 1992-07-14 American Home Products Corporation Aminoesters of rapamycin
PT98990A (pt) 1990-09-19 1992-08-31 American Home Prod Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
US5221670A (en) 1990-09-19 1993-06-22 American Home Products Corporation Rapamycin esters
US5378696A (en) 1990-09-19 1995-01-03 American Home Products Corporation Rapamycin esters
US5233036A (en) 1990-10-16 1993-08-03 American Home Products Corporation Rapamycin alkoxyesters
US5080899A (en) 1991-02-22 1992-01-14 American Home Products Corporation Method of treating pulmonary inflammation
US5078999A (en) 1991-02-22 1992-01-07 American Home Products Corporation Method of treating systemic lupus erythematosus
US5120842A (en) 1991-04-01 1992-06-09 American Home Products Corporation Silyl ethers of rapamycin
US5100883A (en) 1991-04-08 1992-03-31 American Home Products Corporation Fluorinated esters of rapamycin
US5118678A (en) 1991-04-17 1992-06-02 American Home Products Corporation Carbamates of rapamycin
US5118667A (en) 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
US5130507A (en) * 1991-05-23 1992-07-14 Eaton Corporation Capacitive switch assembly
DE69209183T2 (de) 1991-06-18 1996-08-08 American Home Prod Verwendung von Rapamycin zur Behandlung von T-Zellen Lymphom/Leukämie bei Erwachsenen
US5162333A (en) 1991-09-11 1992-11-10 American Home Products Corporation Aminodiesters of rapamycin
US5177203A (en) 1992-03-05 1993-01-05 American Home Products Corporation Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
US5256790A (en) 1992-08-13 1993-10-26 American Home Products Corporation 27-hydroxyrapamycin and derivatives thereof
GB9221220D0 (en) 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US5411967A (en) 1992-10-13 1995-05-02 American Home Products Corporation Carbamates of rapamycin
US5302584A (en) 1992-10-13 1994-04-12 American Home Products Corporation Carbamates of rapamycin
US5480988A (en) 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
US5434260A (en) 1992-10-13 1995-07-18 American Home Products Corporation Carbamates of rapamycin
US5480989A (en) 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
US5489680A (en) 1992-10-13 1996-02-06 American Home Products Corporation Carbamates of rapamycin
US5262423A (en) 1992-10-29 1993-11-16 American Home Products Corporation Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
US5258389A (en) 1992-11-09 1993-11-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
US5260300A (en) 1992-11-19 1993-11-09 American Home Products Corporation Rapamycin carbonate esters as immuno-suppressant agents
US5252579A (en) 1993-02-16 1993-10-12 American Home Products Corporation Macrocyclic immunomodulators
GB9307491D0 (en) 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
ES2295093T3 (es) 1993-04-23 2008-04-16 Wyeth Conjugados y anticuerpos de rapamicina.
AU6711994A (en) 1993-04-23 1994-11-21 American Home Products Corporation Rapamycin conjugates and antibodies
US5504091A (en) 1993-04-23 1996-04-02 American Home Products Corporation Biotin esters of rapamycin
GB2281294A (en) * 1993-08-23 1995-03-01 Fujisawa Pharmaceutical Co Process for producing half esters of the macrolide FK506
US5373014A (en) 1993-10-08 1994-12-13 American Home Products Corporation Rapamycin oximes
US5391730A (en) 1993-10-08 1995-02-21 American Home Products Corporation Phosphorylcarbamates of rapamycin and oxime derivatives thereof
US5378836A (en) 1993-10-08 1995-01-03 American Home Products Corporation Rapamycin oximes and hydrazones
US5385910A (en) 1993-11-22 1995-01-31 American Home Products Corporation Gem-distributed esters of rapamycin
US5385909A (en) 1993-11-22 1995-01-31 American Home Products Corporation Heterocyclic esters of rapamycin
US5385908A (en) 1993-11-22 1995-01-31 American Home Products Corporation Hindered esters of rapamycin
US5389639A (en) 1993-12-29 1995-02-14 American Home Products Company Amino alkanoic esters of rapamycin
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US5463048A (en) 1994-06-14 1995-10-31 American Home Products Corporation Rapamycin amidino carbamates
US5491231A (en) 1994-11-28 1996-02-13 American Home Products Corporation Hindered N-oxide esters of rapamycin
US5563145A (en) 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines
US6261813B1 (en) 1995-09-11 2001-07-17 Albany Molecular Research, Inc. Two step enzymatic acylation
US5780462A (en) 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
WO1998045333A1 (en) 1997-04-09 1998-10-15 Isotechnika, Inc. Method for production of antibodies to specific sites of rapamycin
US6277983B1 (en) 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
US7153983B2 (en) * 2002-03-25 2006-12-26 Council Of Scientific And Industrial Research Chemo-enzymatic process for the preparation of opticaly enriched β-benzyl-γ-butyrolactones
US6745478B2 (en) 2002-07-18 2004-06-08 Delillo Dominick D. Multi-purpose work knife
RU2339639C2 (ru) 2003-08-07 2008-11-27 Уайт Региоселективный синтез cci-779
US7445916B2 (en) * 2004-04-14 2008-11-04 Wyeth Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
KR20070015544A (ko) * 2004-04-14 2007-02-05 와이어쓰 라파마이신 42-에스테르 유도체의 위치특이성 합성
EP1751168A1 (de) * 2004-04-14 2007-02-14 Wyeth Prolin cci-779 (prolin-rapamycin 42-ester mit 2,2-bis(hydroxymethyl)propionsäure) und zweistufige enzymatische synthese von prolin cci-779 und cci-779 mit mikrobieller lipase
RU2007103178A (ru) * 2004-06-30 2008-08-10 Комбинаторкс, Инкорпорейтед (Us) Способы и реагенты для лечения метаболических нарушений

Also Published As

Publication number Publication date
US7445916B2 (en) 2008-11-04
US7625726B2 (en) 2009-12-01
CN1942478A (zh) 2007-04-04
PL1735321T3 (pl) 2009-04-30
MXPA06011882A (es) 2006-12-14
US20050234087A1 (en) 2005-10-20
US20090029426A1 (en) 2009-01-29
WO2005105812A1 (en) 2005-11-10
ES2313328T3 (es) 2009-03-01
CA2562962A1 (en) 2005-11-10
ATE410431T1 (de) 2008-10-15
AU2005238432A1 (en) 2005-11-10
EP1735321B1 (de) 2008-10-08
JP2007532655A (ja) 2007-11-15
BRPI0509810A (pt) 2007-09-18
DE602005010228D1 (de) 2008-11-20
EP1735321A1 (de) 2006-12-27

Similar Documents

Publication Publication Date Title
DK1735321T3 (da) Fremgangsmåde til fremstilling af rapamycin 42-estere og FK-506 32-estere med dicarboxylsyre, precursors for rapamycinkonjugater og antistoffer
WO2003082795A3 (en) METHODS OF MANUFACTURING DERIVATIVES OF β-HYDROXYCARBOXYLIC ACIDS
AP2301A (en) Stereoselective bioconversion of aliphatic dinitriles into cyano carboxylic acids.
CY1111157T1 (el) Μεθοδος για την παρασκευη μεϋτανσινοειδων εστερων
DE60015815D1 (de) Drehendes Reibungsschweissverfahren zur Herstellung eines Bauteils und provisorisches Schweissen von Teilen des Bauteils
RS20080475A (en) Process for the preparation of carboxylic acids and/or derivatives thereof
Sakulsombat et al. In situ evaluation of lipase performances through dynamic asymmetric cyanohydrin resolution
TW200606160A (en) Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
DK1790718T3 (da) Pulverformig lipasesammensætning og fremgangsmåde til fremstilling af forestret produkt under anvendelse af samme
WO2008011033A3 (en) Synthesis of isotopically labeled alpha-keto acids and esters
PT1805316E (pt) Processo para a preparação das formas enantioméricas de derivados de ácido cis-3-hidroxiciclo-hexanocarboxílico utilizando hidrolases
WO2008140074A1 (ja) 光学活性カルボン酸エステルを製造する方法
DE602005012660D1 (de) Verfahren zur Herstellung eines immobilisierten Enzyms
TW200609211A (en) Esterification catalyst and process therewith
DE602007010812D1 (de) Mandelsäurederivate und deren herstellung
DK1339723T3 (da) Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner
WO2008022627A3 (de) Verfahren zur herstellung von optisch aktiven hydroxyalkylacetaten durch racematspaltung von 4-hydr0xy-2-ket0nen unter verwendung von baeyer-vi lliger monooxygenasen
EP1777295A3 (de) Verfahren zur Herstellung von Modafinil
WO2002066990A3 (en) Immobilised cardiolipin probes
WO2006133332A3 (en) Enzyme-catalyzed process for the preparation of macrocyclic polyester oligomers
楊登峰 Structural basis of two novel ketosynthases that catalyze the non-decarboxylative Claisen condensation
IL200537A0 (en) Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt
AU2001282114A1 (en) Method for the production of carboxylic acid benzyl esters
WO2004087284A8 (en) Preparation of a metal chelating separation medium
ATE430205T1 (de) Enantiokonvergente chemisch-enzymatische synthese von (r)-gamma-amino-beta-hydroxybuttersäure ((r) -gabob)